These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 22486168

  • 21. Split stoma in resectional surgery of high-risk patients with ileocolonic Crohn's disease.
    Myrelid P, Söderholm JD, Olaison G, Sjödahl R, Andersson P.
    Colorectal Dis; 2012 Feb; 14(2):188-93. PubMed ID: 21689286
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
    Krygier DS, Ko HH, Bressler B.
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):407-15. PubMed ID: 19673627
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
    Lightner AL, McKenna NP, Tse CS, Raffals LE, Loftus EV, Mathis KL.
    Aliment Pharmacol Ther; 2018 Mar; 47(5):573-580. PubMed ID: 29250800
    [Abstract] [Full Text] [Related]

  • 30. [Recurrence of Crohn's disease after surgery--causes and risks].
    Mirow L, Hauenschild L, Hildebrand P, Kleemann M, Keller R, Franke C, Roblick UJ, Bruch HP, Kujath P.
    Zentralbl Chir; 2008 Apr; 133(2):182-7. PubMed ID: 18415909
    [Abstract] [Full Text] [Related]

  • 31. Meningococcal meningoencephalitis after certolizumab pegol treatment in a patient with Crohn's disease.
    Majumder S, Kumar A.
    J Crohns Colitis; 2013 Feb; 7(1):e19. PubMed ID: 22742971
    [No Abstract] [Full Text] [Related]

  • 32. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients.
    Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P.
    Dis Colon Rectum; 2007 Mar; 50(3):331-6. PubMed ID: 17252288
    [Abstract] [Full Text] [Related]

  • 33. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease.
    Uchino M, Ikeuchi H, Matsuoka H, Bando T, Ichiki K, Nakajima K, Tomita N, Takesue Y.
    Dis Colon Rectum; 2013 Oct; 56(10):1156-65. PubMed ID: 24022533
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The safety of biologic agents in the treatment of inflammatory bowel disease.
    Shepela C.
    Minn Med; 2008 Jun; 91(6):42-5. PubMed ID: 18616021
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease.
    Hanauer SB, Panes J, Colombel JF, Bloomfield R, Schreiber S, Sandborn WJ.
    Aliment Pharmacol Ther; 2010 Aug; 32(3):384-93. PubMed ID: 20491747
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.